Dermata Therapeutics, Inc. (DRMA)
NASDAQ: DRMA · Real-Time Price · USD
0.8400
-0.0299 (-3.44%)
May 5, 2025, 4:00 PM EDT - Market closed
Dermata Therapeutics Market Cap
Dermata Therapeutics has a market cap or net worth of $4.56 million as of May 5, 2025. Its market cap has increased by 132.23% in one year.
Market Cap
4.56M
Enterprise Value
1.40M
1-Year Change
132.23%
Ranking
Category
Stock Price
$0.84
Market Cap Chart
Since the IPO on August 13, 2021, Dermata Therapeutics's market cap has decreased from $57.49M to $4.56M, a decrease of -92.06%. That is a compound annual growth rate of -49.39%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 2, 2025 | 4.72M | 71.47% |
| Dec 31, 2024 | 2.76M | 27.62% |
| Dec 29, 2023 | 2.16M | -56.39% |
| Dec 30, 2022 | 4.95M | -65.84% |
| Dec 31, 2021 | 14.49M | -74.79% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 737.45B |
| Johnson & Johnson | 372.94B |
| UnitedHealth Group | 368.47B |
| AbbVie | 346.84B |
| Novo Nordisk | 309.41B |
| Abbott Laboratories | 230.70B |
| AstraZeneca | 221.69B |
| Novartis AG | 221.37B |